GLP-1 Online Providers: A Factual Comparison
FAQ-000179
Direct Answer
Several GLP-1 online providers currently operate in this space, each with a genuinely different model, Ro, LillyDirect, Hims, Hers, Mochi Health, Piper (now Polly), AltRx, and Medvi among them. This page presents a neutral, factual comparison of what each actually offers, not a ranking of which is "best," since the right choice depends entirely on your specific medical needs, medication type, and what your own provider recommends.
Factual Comparison Table
| Provider | Medication Type Offered | Model | Real, Notable Public Facts |
|---|---|---|---|
| Ro | Branded and compounded options, per its own listing | Telehealth platform with in-house pharmacy network | One of the earlier, more established GLP-1 telehealth platforms |
| LillyDirect | Branded Eli Lilly medications only (Zepbound, Mounjaro, Foundayo) | Manufacturer-direct platform, not an independent telehealth company | Operated directly by the drug manufacturer, not a third-party telehealth provider |
| Hims | Compounded and branded options, per its own listing | Telehealth platform | Broad, general telehealth platform offering GLP-1s alongside other categories |
| Hers | Compounded and branded options, per its own listing | Telehealth platform | Sister platform to Hims, women-focused general telehealth |
| Mochi Health | Compounded and branded options, per its own listing | Telehealth platform | GLP-1-focused telehealth platform |
| Piper (now Polly) | Compounded options, per its own listing | Telehealth platform, rebranded from Piper to Polly | Underwent a real, confirmed name change from Piper to Polly |
| AltRx | Compounded medications | Compounding pharmacy/telehealth | Received a real FDA warning letter (#728236) dated June 8, 2026 for misleading marketing claims |
| Medvi | Compounded medications | Telehealth platform | Received a real FDA warning letter (February 2026); an independent Futurism investigation found AI-generated patient photos on its marketing pages |
Why These Providers Differ Structurally
These aren't interchangeable options. LillyDirect is operated directly by a drug manufacturer and offers only that manufacturer's branded medications. Ro, Hims, Hers, and Mochi Health are independent telehealth platforms offering a mix of branded and compounded options. AltRx and Medvi are more specifically compounding-focused. Understanding which structural category a provider falls into is often more useful than a simple side-by-side "better or worse" comparison.
Real, Documented Regulatory History Worth Knowing
Two providers in this comparison, AltRx and Medvi, have real, documented FDA warning letters on record; Medvi was additionally the subject of an independent Futurism investigation finding AI-generated patient imagery in its marketing. This is presented as factual, publicly documented information, not a claim about current legitimacy, worth reading each provider's dedicated review directly for full context.
Bottom Line
Each of these providers serves a real, distinct role in the current GLP-1 access landscape. The right choice depends on your specific medication needs and what your healthcare provider recommends, not a simple ranking.
Individual Provider Reviews
- Is Ro Legit?
- Is LillyDirect Legit?
- Is Hims Legit for GLP-1?
- Is Hers Legit?
- Is Mochi Health Legit?
- Is Piper (Now Polly) Legit?
- Is AltRx Legit?
- Is Medvi Legit?
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice.
glp-1-online-providers-a-factual-comparison